fluconazole capsules
open joint stock company "borisovskiy zavod medicinskikh preparatov" - fluconazole - capsules - 150mg
fluconazole capsules
open joint stock company "borisovskiy zavod medicinskikh preparatov" - fluconazole - capsules - 50mg
advagraf capsules prolonged-release
astellas ireland co. ltd. - tacrolimus - capsules prolonged-release - 3mg
advagraf capsules prolonged-release
astellas ireland co. ltd. - tacrolimus - capsules prolonged-release - 0,5mg
advagraf capsules prolonged-release
astellas ireland co. ltd. - tacrolimus - capsules prolonged-release - 1mg
advagraf capsules prolonged-release
astellas ireland co. ltd. - tacrolimus - capsules prolonged-release - 5mg
cpg 312 gel breast implant cohesive iii, low height, moderate plus profile
carbosylane
trima israel pharmaceutical products maabarot ltd - charcoal activated; simethicone - capsules - simethicone 45 mg; charcoal activated 140 mg - medicinal charcoal, combinations - medicinal charcoal, combinations - anti-flatulent, for symptomatic treatment of stomach ache resulting from accumulation of gas, relief of sensation of fullness, meteorism, bloating and flatulence.
vyvanse 50 mg
medison pharma ltd - lisdexamfetamine dimesylate - capsules - lisdexamfetamine dimesylate 50 mg - lisdexamfetamine - vyvanse is a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients ages 6 years and above.vyvanse is indicated for the treatment of moderate to severe binge eating disorder (bed) for patient over 18 years.limitation of use:vyvanse is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of vyvanse for the treatment of obesity have not been established